Propranolol is widely employed in hemodialysis patients for the control of renin-dependent hypertension. Infrequent reports have linked hypoglycemia and propranolol, especially in complex situations such as malnutrition, anesthesia, and excessive insulin use. Three patients on maintenance hemodialysis taking propranolol developed severe hypoglycemia resulting in cardiac arrest. The life-threatening hypoglycemia occurred without apparent precipitating cause and unaccompanied by the classical signs and symptoms of hypoglycemia. These three cases suggest that propranolol in a setting of chronic renal failure and dialysis may bring about severe hypoglycemia, a complication previously unsuspected.
AbramsonE.A., ArkyR.A.: Role of beta-adrenergic receptors in counter-regulation to insulin induced hypoglycemia.Diabetes17, 141, 1968.
2.
AbramsonE.A., ArkyR.A., WoeberK.A.: Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycemia.Lancet, ii, 1386, 1966.
3.
BansalV.K., BrooksM.H., YorkJ.C., HanoJ.E.: Intractable hypoglycemia in a patient with renal failure.Arch. Intern. Med.139, 100, 1979.
4.
BlockM.B., RubinsteinA.H.: Spontaneous hypoglycemia in diabetic patients with renal insufficiency.JAMA213, 1863, 1970.
5.
CahillJ.F.Jr.: Starvation in man.N. Engl. J. Med.282, 668, 1970.
6.
ChamberlainM.J., StimmlerL.: The renal handling of insulin.J. Clin. Invest.46, 911, 1967.
7.
DavidD.S., SteereJ.A.C., Pi-SunyerX.F., SakaiS., ClarkS.B.: Aspirin-induced hypoglycaemia in a patient on haemodialysis.Lancetii, 1092, 1971.
8.
FeligP.: The glucose-alanine cycle.Metabolism22, 179, 1973.
9.
FeligP., PozefskyT., MarlissE., CahillG.F.Jr.: Alanine: Key role in gluconeogenesis.Science167, 1003, 1960.
10.
FelmanH.A., SingerI.: Endocrinology and metabolism in uremia and dialysis: A clinical review.Medicine54, 345, 1974.
GarberA.J., BierD.M., CryerP.E., PagliaraA.S.: Hypoglycemia in compensated chronic renal insufficiency.Substrate limitation of gluconeogenesis. Diabetes23, 982, 1974.
13.
HruskaK.A., BlondinJ., BassR., SantiagoJ., ThomasL., AltshelerP., MartinK., KlahrS.: Effect of intact parathyroid hormone on hepatic glucose release in the dog.J. Clin. Invest.64, 1016, 1979.
14.
KlahrS., NawarT., SchoolwerthA.C.: Effects of catecholamines on ammoniagenesis and gluconeogenesis by renal cortex in vitro.Biochem. Biophy. Acta304, 161, 1973.
15.
LinderA., DouglasS.W., AdamsonJ.W.: Propranolol effects in long-term hemodialysis patients with renin-dependent hypertension.Ann. Intern. Med.88, 457, 1978.
SamiiK., CiancioniC., RottembourgJ., BisselichesF., JacobsC.: Severe hypoglycemia due to beta blocking drugs in hemodialysis patients.Lancet1, 545, 1976.
24.
ShandD.G.: Propranolol.N. Engl. J. Med.293, 280, 1975.
25.
SkinnerD.J., MisbinR.I.: Use of propranolol.N. Engl. J. Med.293, 1205, 1975.
26.
Waal-ManningH.J.: Hypertension: Which beta-blocker?Drugs12, 412, 1976.
WhiteM.G., KurtzmanA.: Hypoglycemia in diabetes with renal insufficiency.JAMA215, 117, 1971.
29.
ZaharkoD.S., BeckL.V., BlankenbakerR.: Role of the kidney in the disposal of radioiodinated and non-radioiodinated insulin in dogs.Diabetes15, 680, 1966.
